Computational Studies on T2Rs Agonist-Based Anti–COVID-19 Drug Design

The expeditious and world pandemic viral disease of new coronavirus (SARS-CoV-2) has formed a prompt urgency to discover auspicious target-based ligand for the treatment of COVID-19. Symptoms of novel coronavirus disease (COVID-19) typically include dry cough, fever, and shortness of breath. Rece...

Full description

Bibliographic Details

Main Author:	Selvakumar Paulraj, Mosae
Format:	Article
Language:	English
Published:	frontiers in Micrology 2025
Subjects:	coronavirus (COVID−19), molecular docking, T2Rs agonist, drug design, spike (S) glycoprotein
Online Access:	https://repository.auw.edu.bd/handle/123456789/962